Your search returned 14 results.

Results
	1.	Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line. [electronic resource] by Arencibia, J M Schally, A V Producer: 20000522 In: International journal of oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses. [electronic resource] by Arencibia, J M Schally, A V Halmos, G Nagy, A Kiaris, H Producer: 20010531 In: Anti-cancer drugs vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma. [electronic resource] by Koppán, M Halmos, G Arencibia, J M Lamharzi, N Schally, A V Producer: 19981016 In: Cancer vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. [electronic resource] by Halmos, G Arencibia, J M Schally, A V Davis, R Bostwick, D G Producer: 20000210 In: The Journal of urology vol. 163 Availability: No items available. Save to lists Add to cart (remove)
	5.	Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix. [electronic resource] by Chatzistamou, I Schally, A V Szepeshazi, K Groot, K Hebert, F Arencibia, J M Producer: 20010920 In: Cancer letters vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207. [electronic resource] by Kahán, Z Nagy, A Schally, A V Halmos, G Arencibia, J M Groot, K Producer: 19990630 In: Cancer vol. 85 Availability: No items available. Save to lists Add to cart (remove)
	7.	Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses. [electronic resource] by Koppan, M Nagy, A Schally, A V Arencibia, J M Plonowski, A Halmos, G Producer: 19981001 In: Cancer research vol. 58 Availability: No items available. Save to lists Add to cart (remove)
	8.	Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice. [electronic resource] by Kahán, Z Nagy, A Schally, A V Halmos, G Arencibia, J M Groot, K Producer: 20000921 In: Breast cancer research and treatment vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice. [electronic resource] by Koppán, M Nagy, A Schally, A V Plonowski, A Halmos, G Arencibia, J M Groot, K Producer: 19990224 In: The Prostate vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238. [electronic resource] by Plonowski, A Schally, A V Koppan, M Nagy, A Arencibia, J M Csernus, B Halmos, G Producer: 20011004 In: Cancer vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness. [electronic resource] by Arencibia, J M Schally, A V Krupa, M Bajo, A M Nagy, A Szepeshazi, K Plonowski, A Producer: 20011004 In: International journal of oncology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II. [electronic resource] by Kahán, Z Sun, B Schally, A V Arencibia, J M Cai, R Z Groot, K Halmos, G Producer: 20000427 In: Cancer vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs. [electronic resource] by Szepesházi, K Halmos, G Schally, A V Arencibia, J M Groot, K Vadillo-Buenfil, M Rodriguez-Martin, E Producer: 19990917 In: Journal of cancer research and clinical oncology vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. [electronic resource] by Kahán, Z Arencibia, J M Csernus, V J Groot, K Kineman, R D Robinson, W R Schally, A V Producer: 19990225 In: The Journal of clinical endocrinology and metabolism vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)